U.S. Medical Equipment Stock News

Recent coverage has highlighted that Origin Bancorp is currently offering a dividend yield of about 2.2% and has raised its payout twice in the past five years, with analysts also pointing to expectations for stronger earnings in 2026. This combination of consistent dividend growth and an earnings outlook that supports further distributions has drawn attention to Origin Bancorp’s role for income-focused investors. Next, we’ll examine how this focus on dividend growth and earnings...

Evercore has recently expanded its senior ranks, appointing Clay McCoy and Chris Connelly as senior managing directors in its private capital advisory and industrials investment banking groups, alongside hiring veteran trader Mark Hibbert to its equities business. Together, these hires point to a clear push to deepen Evercore’s expertise in private capital, business services, and cross-asset trading, reinforcing its focus on complex advisory mandates. We’ll now examine how Evercore’s latest...

Earlier in May 2026, Brunswick Corporation announced that its boats, Mercury Marine propulsion, and Navico Group electronics will serve as the platform for Textron Systems’ TSUNAMI uncrewed surface vessels, which recently supported U.S. Navy experimentation exercises in Key West following a Defense Innovation Unit contract award. This collaboration underscores how Brunswick’s integrated marine technologies are being applied to defense and autonomous maritime applications, potentially...

Ellington Financial (EFC) has been drawing attention after posting annual revenue of US$399.872 million and net income of US$182.561 million. These figures invite closer inspection of this mortgage focused REIT’s income profile. See our latest analysis for Ellington Financial. Recent moves in Ellington Financial's stock suggest steady but measured momentum, with a 90 day share price return of 8.43% and a 1 year total shareholder return of 20.75% framing the revenue and earnings story against...

If you are wondering whether USA TODAY at US$7.45 is still interesting after a strong run, the key question is how that price compares with the value of the business. The stock is up 43.0% year to date and 113.5% over the past year, even though it slipped 0.7% over the last week and is up 3.9% over the past month. That kind of movement can change how you think about both risk and potential upside. Recent coverage has focused on USA TODAY as a media stock that has attracted attention after a...

Cousins Properties recently reported past first-quarter 2026 results showing 932,000 square feet of new leases signed and portfolio occupancy improving to 88.9% across its Class A Sun Belt office portfolio. A key insight is that this leasing progress supported an upward revision to the company’s 2026 funds-from-operations-per-share estimate, reinforcing confidence in its operating momentum. We’ll now examine how this stronger leasing momentum and higher occupancy could influence Cousins...

Oceaneering International (OII) has announced that its Offshore Projects Group won an integrated offshore installation contract from Burullus Gas Company for Egypt’s West Delta Deep Marine project, covering subsea infrastructure, ROV support, and survey services. See our latest analysis for Oceaneering International. At a share price of US$38.40, Oceaneering International has delivered a 54.53% year to date share price return and a 1 year total shareholder return of 103.17%. This suggests...

Erie Indemnity (ERIE) is back in focus after its FY2026 Q1 earnings report, where operating revenue and income rose but earnings missed expectations, and the stock saw a mixed share price reaction. See our latest analysis for Erie Indemnity. Since the earnings miss, Erie Indemnity's share price has been under pressure, with a 30 day share price return down 12.44% and year to date share price return down 20.06%. However, the 5 year total shareholder return of 24.72% reflects a much steadier...

Keysight Technologies (KEYS) has reported Q1 2026 revenue of US$1.6 billion and basic EPS of US$1.63, supported by trailing twelve month revenue of US$5.7 billion and EPS of US$5.71. This compares with a 60.6% year over year earnings increase and an improved net profit margin of 17.3% versus 12.2% a year earlier. Over recent quarters the company’s revenue has moved from US$1.29 billion in Q1 2025 to US$1.42 billion in Q4 2025 and US$1.6 billion in Q1 2026. Basic EPS has followed a similar...

We'd be surprised if Artiva Biotherapeutics, Inc. ( NASDAQ:ARTV ) shareholders haven't noticed that the President, Fred...

Recent analyst revisions to earnings estimates for Skyward Specialty Insurance Group (SKWD) have drawn fresh attention to the stock, with sentiment also supported by favorable momentum rankings and reports of continued market share gains. See our latest analysis for Skyward Specialty Insurance Group. At a share price of $47.39, Skyward Specialty Insurance Group has seen a 7 day share price return of 7.63%, while its 1 year total shareholder return has declined 23.44%. However, the 3 year...

Newell Brands (NasdaqGS:NWL) is launching a limited edition Sharpie and Elmer's collection tied to Disney and Pixar's upcoming Toy Story 5. The range features Toy Story characters and themed designs and is expected to appear across major retailers such as Amazon, Walmart, and Target. The collaboration targets both children and adults, aiming to connect with fans of the franchise ahead of the film's release. For Newell Brands, best known in this context for its Sharpie and Elmer's lines,...

Solventum overview and recent performance Solventum (SOLV) has drawn fresh attention as a standalone healthcare company, with investors weighing its recent trading performance against fundamentals such as revenue of US$8.26b and net income of US$1.43b. See our latest analysis for Solventum. At a share price of US$76.13, Solventum has delivered a 1-month share price return of 8.7% and a 1-year total shareholder return of 4.63%, suggesting recent momentum has improved after weaker year to date...

Without a specific news trigger, eToro Group (NasdaqGS:ETOR) is drawing attention for its recent share performance, with the stock up 1.7% over the past month and 27.7% over the past 3 months. See our latest analysis for eToro Group. That short term momentum, with a 1 month share price return of 1.7% and a 3 month share price return of 27.7%, sits against a very weak 1 year total shareholder return, which is down 39.6%. If you are comparing eToro Group with other opportunities in similar...

In May 2026, Novanta Inc. reported first-quarter sales of US$257.71 million with essentially flat net income year over year, issued second-quarter and full-year 2026 revenue guidance of US$259 million to US$264 million and US$1.04 billion to US$1.06 billion respectively, and reiterated acquisitions and manufacturing optimization as core priorities. Management also highlighted record bookings, strong momentum in Robotics & Automation and Advanced Surgery, and a disciplined acquisition...

Wondering if American Electric Power Company at US$128.87 is offering fair value today, or if the price is running ahead of itself? This article focuses squarely on what the numbers say about the stock. The stock is up 0.7% over the past week and 11.3% year to date, while the 1 year and 5 year returns sit at 29.2% and 80.0%. These figures can influence how the market is thinking about both upside and risk. Recent news coverage has centered on American Electric Power Company as a large...

DENTSPLY SIRONA (XRAY) stock has drawn attention after a period of weak share performance, with the price around $9.84 and total returns down over the past year and over the past 3 months. See our latest analysis for DENTSPLY SIRONA. The recent 1-day share price return of 1.03% sits against a 30-day share price return that is down 23.06% and a 1-year total shareholder return that is down 35.47%, suggesting momentum has been fading rather than building. If this kind of volatility has you...

Wondering if IQVIA Holdings at around US$171.50 is offering value right now, or if you are paying up for growth expectations that may already be in the price. The stock is roughly flat over the past week, down around 3% over the past month and down 23.9% year to date, yet it is still up 24.9% over the past year. This can leave investors questioning whether the recent weakness signals changing risk sentiment or just normal volatility. Recent headlines have focused on IQVIA Holdings' role in...

Wondering whether Littelfuse at around US$441 per share still offers value or if the easy gains are behind it? This article walks through what the current price may say about expectations baked into the stock. The share price has been through a sharp pullback of about 8.3% over the past week, after a strong 11.8% move over the last month and sizeable returns of 68.1% year to date and 111.9% over the past year. Recent headlines around Littelfuse have focused on its positioning within the...

Investors may be wondering whether Black Stone Minerals, at around US$13.93, is offering good value right now or if most of the potential upside is already reflected in the price. The stock has returned 2.8% over the past week, 1.2% over the past month, 3.1% year to date and 12.9% over the last year. This naturally raises questions about how much risk and reward are currently embedded in the price. Recent coverage has focused on Black Stone Minerals as an income-oriented US energy stock and...

If you are wondering whether Omnicell's current share price still reflects good value or if most of the opportunity is already priced in, the starting point is understanding how its valuation stacks up across several methods. Over the past year, the stock is up 63.6%, with a 3.6% gain over the last week and 18.3% over the past month, even though the year to date return is slightly down at 0.9% and longer term 3 year and 5 year returns are lower at 38.8% and 67.7% respectively. These price...

Structure Therapeutics (GPCR) drew fresh attention after reporting first quarter results for the period ended March 31, 2026, with a net loss of US$75.97 million compared with US$46.83 million a year earlier. See our latest analysis for Structure Therapeutics. The first quarter update and wider clinical pipeline work have come against a backdrop of a share price that is down 23.5% over the past month and 45.9% year to date, while the 1 year total shareholder return of 52.7% and 3 year total...

IDEAYA Biosciences (IDYA) is back in focus after reporting OptimUM-02 data showing longer median progression-free survival for its lead melanoma drug, darovasertib, and signaling plans for an NDA filing and broader pipeline expansion. See our latest analysis for IDEAYA Biosciences. IDEAYA's recent darovasertib update comes after a choppy few months, with the share price up 4.7% over the last day and 2.6% over the past week, but down around 12% year to date. The 1 year total shareholder return...

ICL Group (NYSE:ICL) is expanding in China with a new food specialty plant, targeting higher value ingredients for the local market. The company has also entered a major distribution agreement in China to widen access to its specialty products. At the same time, ICL is growing its specialty fertilizers business in North America, adding another leg to its international buildout. ICL Group operates across specialty minerals, advanced fertilizers and food ingredients, so these moves align...